Cord Blood Banking Services Market

Increasing awareness regarding the tremendous therapeutic potential of stem cells boosts market growth.

The increasing awareness regarding the tremendous therapeutic potential of stem cells is spurring the growth of the market. Currently, the use of stem cells is rising in numerous diseases, such as chronic diseases and traumatic injuries, owing to irreparable damage. The irreparable damage can be at the end of the fingertip, where stem cells have the ability to regenerate the damaged tissues. Moreover, diseases such as liver failure or diabetes show high prevalence worldwide, which is driving the market's growth.

For instance, as per the Diabetes Atlas 2021, there were 537 million adults living with diabetes, and it was predicted to reach 783 million by 2045.

The Global Cord Blood Banking Services Market Industry is poised for substantial growth, with projections indicating an increase in market value from 1.6 USD Billion in 2024 to approximately 6.66 USD Billion by 2035. This remarkable growth trajectory suggests a compound annual growth rate (CAGR) of 13.84% from 2025 to 2035, reflecting the increasing demand for cord blood banking services. Factors contributing to this growth include rising awareness of the benefits of cord blood, advancements in storage technology, and the growing incidence of chronic diseases. Such projections highlight the market's potential and the evolving landscape of healthcare solutions.

The globalization of healthcare services is a key driver of the Global Cord Blood Banking Services Market Industry, facilitating access to advanced medical technologies and treatments across borders. As healthcare systems worldwide become more interconnected, families are increasingly aware of the benefits of cord blood banking, not only for local use but also for potential international applications. This trend is likely to enhance market growth, as families seek to secure the best possible health outcomes for their children. The anticipated CAGR of 13.84% from 2025 to 2035 suggests that the market will continue to expand, driven by the increasing integration of global healthcare practices.

The Global Cord Blood Banking Services Market Industry is significantly influenced by the rising incidence of chronic diseases, which has heightened the demand for innovative treatment options. As conditions such as leukemia, lymphoma, and other genetic disorders become more prevalent, the potential for cord blood-derived stem cells to provide therapeutic solutions becomes increasingly relevant. This growing need for alternative treatments is likely to drive families to consider cord blood banking as a proactive health measure. The market's expansion reflects this trend, with projections indicating a substantial increase in value, potentially reaching 6.66 USD Billion by 2035.

Regulatory frameworks and standardization efforts contribute to the stability and growth of the Global Cord Blood Banking Services Market Industry. Governments and health organizations are increasingly establishing guidelines that ensure the safety and efficacy of cord blood banking practices. This regulatory support fosters consumer trust and encourages more families to consider cord blood banking as a secure option. As the market evolves, adherence to these regulations is likely to enhance operational standards across the industry, potentially leading to a compound annual growth rate (CAGR) of 13.84% from 2025 to 2035. Such growth underscores the importance of regulatory compliance in shaping market dynamics.

The Global Cord Blood Banking Services Market Industry experiences growth driven by heightened awareness among expectant parents regarding the advantages of cord blood banking. Educational initiatives and outreach programs have been instrumental in disseminating information about the potential uses of cord blood in treating various diseases, including certain cancers and genetic disorders. As of 2024, the market is valued at approximately 1.6 USD Billion, reflecting a growing recognition of the importance of preserving stem cells for future medical applications. This trend is likely to continue, as more families consider cord blood banking as a viable option for safeguarding their children's health.

Technological innovations play a pivotal role in the Global Cord Blood Banking Services Market Industry, enhancing the efficiency and safety of cord blood storage. Advances in cryopreservation techniques and automated storage systems have improved the viability of stem cells, ensuring higher success rates in potential therapeutic applications. These developments not only bolster consumer confidence but also attract investment into the sector. The market is projected to grow significantly, with estimates suggesting a rise to 6.66 USD Billion by 2035. This growth trajectory indicates a robust demand for advanced storage solutions that meet the evolving needs of healthcare providers and families alike.

By Region, the study segments the market into North America, Europe, Asia-Pacific, and Rest of the World. North America cord blood banking services market accounted for the largest market share due to the availability of well-developed healthcare infrastructure, growing healthcare expenditure and rising awareness associated with available services.

Further, the major countries studied are: The US, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 3: Cord Blood Banking Services Market Share by Region 2022 (%)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe cord blood banking services market accounts for the second-largest market share due to the increased burden of chronic diseases such as cancer and diabetes as well as presence of large cord blood banks are driving the region’s market growth. For instance, in December 2022, Famicord Group (Italy), announced that it has stored 600,000 samples supplied stem cells for treatment of around 3450 patients in more than 35 countries. Furthermore, the Germany market of cord blood banking services the largest market share, and the UK market of cord blood banking services was the fastest growing market in the Europe region.

The Asia-Pacific market of cord blood banking services is expected to grow at a significant share from 2024 to 2032. This is due to increasing awareness of storing stem cells and advanced healthcare reforms across the region. In recent years, Malaysia, India, Indonesia, and China have demonstrated better opportunities for the market growth of the cord blood banking services. The endeavor of placing notice boards and charts in several hospitals and health care centres in these countries has increased awareness of the subject.

Moreover, China market of cord blood banking services held the largest market share, and the India market of Cord blood banking services was the fastest growing market in the Asia-Pacific region.

Major market players are spending a lot of money on R&D to increase their product lines, which will help to market growth of cord blood banking services even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, including new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the cord blood banking services industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.

Americord Registry LLC (US) specializes in the banking of umbilical cord blood, cord tissue, and placenta stem cells. In February 2022, the company announced the opening of R&D facilities and a cell processing unit in New York, US, to provide solutions to families facing clinical needs.

Additionally, CordVida (Brazil) is a leading national stem cell bank in Brazil, with the most transplants and the highest average cell count of stored units among private cord blood banks in the country. In April 2021, the company acquired CryoHoldco (Mexico) to consolidate the laboratory operations in Sau Paulo for all CordVida companies in Brazil.